PL372305A1 - Sposób wytwarzania chlorowodorku paroksetyny, który ogranicza tworzenie się zabarwionych na różowo związków - Google Patents
Sposób wytwarzania chlorowodorku paroksetyny, który ogranicza tworzenie się zabarwionych na różowo związkówInfo
- Publication number
- PL372305A1 PL372305A1 PL02372305A PL37230502A PL372305A1 PL 372305 A1 PL372305 A1 PL 372305A1 PL 02372305 A PL02372305 A PL 02372305A PL 37230502 A PL37230502 A PL 37230502A PL 372305 A1 PL372305 A1 PL 372305A1
- Authority
- PL
- Poland
- Prior art keywords
- colored compounds
- pink colored
- paroxetine hcl
- limits formation
- preparing paroxetine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29860301P | 2001-06-14 | 2001-06-14 | |
US32699301P | 2001-10-05 | 2001-10-05 | |
US34604802P | 2002-01-04 | 2002-01-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL372305A1 true PL372305A1 (pl) | 2005-07-11 |
Family
ID=27404578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL02372305A PL372305A1 (pl) | 2001-06-14 | 2002-06-14 | Sposób wytwarzania chlorowodorku paroksetyny, który ogranicza tworzenie się zabarwionych na różowo związków |
Country Status (17)
Country | Link |
---|---|
US (1) | US20030083501A1 (pl) |
EP (1) | EP1406625A4 (pl) |
JP (1) | JP2005501819A (pl) |
KR (1) | KR20040064615A (pl) |
CN (1) | CN1516585A (pl) |
CA (1) | CA2447808A1 (pl) |
CZ (1) | CZ20033574A3 (pl) |
HR (1) | HRP20040015A2 (pl) |
HU (1) | HUP0400216A2 (pl) |
IL (1) | IL159280A0 (pl) |
IS (1) | IS7074A (pl) |
MX (1) | MXPA03011594A (pl) |
NO (1) | NO20035547D0 (pl) |
PL (1) | PL372305A1 (pl) |
SK (1) | SK12004A3 (pl) |
TR (1) | TR200302081T2 (pl) |
WO (1) | WO2002102382A1 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6777554B2 (en) * | 2001-02-05 | 2004-08-17 | Teva Pharmaceutical Industries Ltd. | Preparation of N-methylparoxetine and related intermediate compounds |
EP1555262A4 (en) * | 2002-09-19 | 2008-04-16 | Sumitomo Chemical Co | METHOD OF CRYSTAL EXPOSURE |
DE10327517A1 (de) | 2003-06-17 | 2005-01-13 | Ht Troplast Ag | Ionenleitende thermoplastische Zusammensetzungen für elektrochrome Verglasungen |
EP1885708A2 (en) * | 2005-04-15 | 2008-02-13 | Board of Trustees of Michigan State University | Gpcr modulators |
GB201108345D0 (en) * | 2011-05-18 | 2011-06-29 | Aesica Pharmaceuticals Ltd | Process |
US9254281B2 (en) * | 2011-09-12 | 2016-02-09 | Wright State University | Composition and method for the treatment of neurodegeneration |
CN112159398A (zh) * | 2020-10-12 | 2021-01-01 | 浙江华海药业股份有限公司 | 一种盐酸帕罗西汀的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
US5856493A (en) * | 1995-02-06 | 1999-01-05 | Smithkline Beecham Corporation | Process for making novel form of paroxeting hydrochloride anhydrate |
CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
ES2331937T3 (es) * | 1996-06-13 | 2010-01-20 | Sumitomo Chemical Company, Limited | Derivados de piperidina como intermediarios para la preparacion de paroxetina y procedimiento de preparacion de los mismos. |
HU221921B1 (hu) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
US5672612A (en) * | 1996-09-09 | 1997-09-30 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
CA2187128A1 (en) * | 1996-10-04 | 1997-06-26 | K. S. Keshava Murthy | New and useful polymorph of anhydrous paroxetine hydrochloride |
CA2193939C (en) * | 1996-12-24 | 2002-02-12 | K.S. Keshava Murthy | Useful form of anhydrous paroxetine hydrochloride |
PT994872E (pt) * | 1997-06-10 | 2001-09-28 | Synthon Bv | Composto de 4-fenilpiperidina |
GB9808896D0 (en) * | 1998-04-25 | 1998-06-24 | Smithkline Beecham Plc | Novel compound |
GB9826180D0 (en) * | 1998-11-30 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
WO2002017921A2 (en) * | 2000-08-28 | 2002-03-07 | Synthon B.V. | Paroxetine compositions and processes for making the same |
-
2002
- 2002-06-04 IL IL15928002A patent/IL159280A0/xx unknown
- 2002-06-14 CN CNA028118901A patent/CN1516585A/zh active Pending
- 2002-06-14 CZ CZ20033574A patent/CZ20033574A3/cs unknown
- 2002-06-14 HU HU0400216A patent/HUP0400216A2/hu unknown
- 2002-06-14 KR KR10-2003-7016187A patent/KR20040064615A/ko not_active Application Discontinuation
- 2002-06-14 TR TR2003/02081T patent/TR200302081T2/xx unknown
- 2002-06-14 PL PL02372305A patent/PL372305A1/pl not_active Application Discontinuation
- 2002-06-14 SK SK1-2004A patent/SK12004A3/sk not_active Application Discontinuation
- 2002-06-14 US US10/172,521 patent/US20030083501A1/en not_active Abandoned
- 2002-06-14 JP JP2003504969A patent/JP2005501819A/ja active Pending
- 2002-06-14 WO PCT/US2002/019016 patent/WO2002102382A1/en not_active Application Discontinuation
- 2002-06-14 EP EP02752054A patent/EP1406625A4/en not_active Withdrawn
- 2002-06-14 MX MXPA03011594A patent/MXPA03011594A/es unknown
- 2002-06-14 CA CA002447808A patent/CA2447808A1/en not_active Abandoned
-
2003
- 2003-12-12 NO NO20035547A patent/NO20035547D0/no unknown
- 2003-12-12 IS IS7074A patent/IS7074A/is unknown
-
2004
- 2004-01-09 HR HR20040015A patent/HRP20040015A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0400216A2 (hu) | 2004-07-28 |
KR20040064615A (ko) | 2004-07-19 |
CA2447808A1 (en) | 2002-12-27 |
MXPA03011594A (es) | 2005-09-08 |
IS7074A (is) | 2003-12-12 |
HRP20040015A2 (en) | 2004-10-31 |
TR200302081T2 (tr) | 2004-09-21 |
WO2002102382A9 (en) | 2003-03-06 |
WO2002102382A1 (en) | 2002-12-27 |
CZ20033574A3 (cs) | 2004-09-15 |
JP2005501819A (ja) | 2005-01-20 |
SK12004A3 (en) | 2004-05-04 |
EP1406625A4 (en) | 2005-03-23 |
CN1516585A (zh) | 2004-07-28 |
IL159280A0 (en) | 2004-06-01 |
US20030083501A1 (en) | 2003-05-01 |
EP1406625A1 (en) | 2004-04-14 |
NO20035547D0 (no) | 2003-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL395097A1 (pl) | Sposób wytwarzania związku o wzorze A stanowiącego pochodną tiofenu | |
HK1069578A1 (en) | Method for preparing benzenesulfonyl compounds | |
GB0129611D0 (en) | Process for production of styrene | |
HUP0402027A3 (en) | Process for the preparation of a xantophyll | |
PL360357A1 (pl) | Sposób wytwarzania zeolitu zawierającego tytan | |
HK1063803A1 (en) | Process for the preparation of a 14-hydroxynormorphinone derivative | |
IL159280A0 (en) | A process for preparing paroxetine hcl which limits formation of pink colored compounds | |
IL159304A0 (en) | Process for the production of piperidine derivatives | |
EP1491520A4 (en) | PROCESS FOR PREPARING BISPHENOL A | |
PL360356A1 (pl) | Sposób wytwarzania zeolitu zawierającego tytan | |
IL148376A0 (en) | A method for the production of pure silica | |
EP1547993A4 (en) | PROCESS FOR PREPARING SPIROFLUORENOLS | |
SG108831A1 (en) | Process for preventing formation of scale | |
EP1444263A4 (en) | METHOD FOR IMPROVING THE STABILITY OF A BONE BINDING IMPLANT | |
TWI318971B (en) | Process for production of bisphenol a | |
AU2002308986A1 (en) | Process for preparation of a quinolinecarbaldehyde | |
EP1539772A4 (en) | PROCESS FOR PREPARING PHOSPHORDIAMIDITE COMPOUNDS | |
EP1406624A4 (en) | METHOD FOR PRODUCING PAROXETIN, WHICH IS ESPECIALLY FREE OF ALKOXY POLLUTION | |
EP1461013A4 (en) | PROCESS FOR PRODUCING A NICOTINE COMPOSITION | |
GB0113318D0 (en) | Method for production of a protein | |
AU2002352423A8 (en) | Process for the manufacture of pharmaceutically acceptable salts of a compound | |
HU0101212D0 (en) | Method for producing of buiding material | |
AU2002225426A1 (en) | Process for preparation of benzylpiperidine compounds | |
HU0102748D0 (en) | Method for producing of cemetous material | |
TW501419U (en) | Forming mechanism for outward-turning forming machine of toecap |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |